Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

TIMP3 (D74B10) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

TINF2 antibody


Biorbyt logo
View Antibody details

Tinurilimab Biosimilar – Anti-CEACAM6 mAb – Research Grade


View Antibody details

TIPE2 (E5Q2S) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

TIPE2 (E5Q2S) Rabbit mAb (Alexa Fluor® 488 Conjugate)


Cell Signalling Technology logo
View Antibody details

TIPRL Mouse Monoclonal Antibody [Clone ID: LBI3D11]


View Antibody details

Tiragolumab Biosimilar – Anti-TIGIT/ VSIG9/ VSTM3 mAb – Research Grade


View Antibody details

TIRAP (D6M9Z) Rabbit mAb


Cell Signalling Technology logo
View Antibody details

Tirnovetmab Biosimilar – Anti-IL31 (Canine) mAb – Research Grade


View Antibody details

Tislelizumab Biosimilar – Anti-PDCD1/ PD1/ CD279 mAb – Research Grade


View Antibody details